Bioceres Crop Solutions Subsidiary Rizobacter Completes $16.1 Million Offering of Series VI Corporate Bonds

Rhea-AI Summary

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that its subsidiary Rizobacter Argentina S.A. has successfully completed a $16.1 million public offering of Series VI corporate bonds in Argentina. The offering consists of two tranches: Class A, totaling $12.7 million with a maturity in March 2023 at an interest rate of 3.75%, and Class B, amounting to $3.4 million with a maturity in September 2024 at 5.25%. Proceeds will support working capital, extend debt maturities, and lower financing costs.

Positive

• Successful completion of a $16.1 million bond offering.
• Improvement in cash flow through working capital support.
• Extended debt maturities will reduce financing costs.

Negative

• None.

ROSARIO, Argentina--(BUSINESS WIRE)-- Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that its subsidiary Rizobacter Argentina S.A. (“Rizobacter”) has completed a $16.1 million public offering of Series VI corporate bonds in the Argentine market. The bonds will be issued in two tranches:

Class A: $12.7 million with maturity in March 2023 and an annual nominal interest rate of 3.75%; and

Class B: $3.4 million with maturity in September 2024 and an annual nominal interest rate of 5.25%.

Proceeds will be used to support working capital as well as for general corporate purposes, while extending debt maturities and reducing financing costs.

About Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated global provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4® program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, click here.

Forward-looking statements

This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals, including the uncertainties relating to the impact of COVID-19 on the Company’s business, operations, liquidity and financial results and the other factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210903005036/en/

Investor Relations Contact

Chris Tyson

Executive Vice President

MZ Group – MZ North America

(949) 491-8235

BIOX@mzgroup.us

www.mzgroup.us

Bioceres Crop Solutions

Máximo Goya, Investor Relations

+54-341-4861100

maximo.goya@biocerescrops.com

Source: Bioceres Crop Solutions Corp.

FAQ

What is the purpose of Bioceres' recent bond offering?

The bond offering will support working capital and general corporate purposes, extend debt maturities, and reduce financing costs.

What are the details of the bonds issued by Bioceres?

Bioceres issued $16.1 million in corporate bonds, with Class A at $12.7 million due in March 2023 at 3.75% interest, and Class B at $3.4 million due in September 2024 at 5.25% interest.

How will the bond offering affect Bioceres' financial position?

The bond offering is expected to enhance cash flow and reduce financing costs by extending the maturity of existing debts.

When do the bonds issued by Bioceres mature?

Class A bonds mature in March 2023, and Class B bonds mature in September 2024.